SCHEMBL18535640

SCHEMBL18535640

CCCC1CCC(C)CN(C)C1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20849719 0.86 SLC6A3 (0.37) SLC6A3
SCHEMBL10229155 0.83
SCHEMBL92504 0.79
SCHEMBL23251417 0.78
SCHEMBL255098 0.78
SCHEMBL13479302 0.78
SCHEMBL12201932 0.76
Fluoride SCHEMBL30212665 0.76 NCF1 (0.44) SLC6A3
Hydrochloric Acid SCHEMBL30212997 0.76 NCF1 (0.44) SLC6A3
SCHEMBL23761195 0.75 ATM (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2995618-B1 [1,2,4]TRIAZOL [4,3-A]PYRIDINE DERIVATE, PREPARATION METHOD THEREFOR OR MEDICAL APPLICATION THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD (CN) 2019-01-09 EP disclosed
EP-2900672-B1 BET-PROTEIN INHIBITORY 5-ARYL-TRIAZOLO-AZEPINES Bayer Pharma AG (DE) 2017-02-22 EP disclosed